Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Mokari Atabak. Officer active across 1 company, notably CORCEPT THERAPEUTICS INC. Aggregated, 14 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €2.4m. History available since 1 September 2022. The latest transaction was filed on 2 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
40,000 shares@ US$19.260.011% mcap20.2% of flowCommon StockSEC:0001193125-26-256011:0
40,000 shares@ US$70.00010.040% mcap73.3% of flowCommon StockSEC:0001193125-26-256011:1
634 shares@ US$70.440.0006% mcap1.2% of flowCommon StockSEC:0001193125-26-256011:2
634 shares0Common StockSEC:0001193125-26-256011:3
395 shares@ US$70.440.0004% mcap0.7% of flowCommon StockSEC:0001193125-26-256011:4
228 shares@ US$60.580.4% of flowCommon StockSEC:0000950170-25-032725:0
182 shares@ US$57.680.3% of flowCommon StockSEC:0000950170-24-133432:0
571 shares@ US$30.170.5% of flowCommon StockSEC:0000950170-24-069598:0
517 shares@ US$24.060.3% of flowCommon StockSEC:0000950170-24-026760:0
508 shares@ US$25.970.4% of flowCommon StockSEC:0000950170-23-068364:0
398 shares@ US$33.100.4% of flowCommon StockSEC:0000950170-23-046818:0
1,651 shares@ US$22.971.1% of flowCommon StockSEC:0000899243-23-014514:0
1,260 shares@ US$19.860.7% of flowCommon StockSEC:0000899243-23-007054:0
793 shares@ US$25.980.6% of flowCommon StockSEC:0000899243-22-030514:0